Hospital Admissions for Surgery Double When Abortion Pill Complications Are Miscoded As Natural Miscarriage Washington, D.C. – A new analysis of 423,000 confirmed abortions debunks the common abortion industry narrative that “there’s no medical reason to tell a doctor about an abortion.” According to the new study from Charlotte Lozier Institute (CLI), if […]
Multiple Studies Link Chemical Abortion to Higher Rates of Emergency Room Utilization and Complications Washington, D.C. – Half of all Connecticut abortions are performed with potentially dangerous drugs which multiple peer-reviewed studies have linked to higher rates of complications. Publicly available data collected by the Connecticut Department of Public Health and analyzed by […]
FDA Must Consider Comprehensive Medicaid Data That Disproves Abortion Industry Claims Regarding “Safety” of Chemical Abortion Washington, D.C. – As the Food and Drug Administration (FDA) works toward a December 16 decision on chemical abortion safeguards, a groundbreaking new study from Charlotte Lozier Institute (CLI) shows that increased access to abortion pills creates a […]